MS Australia’s Response to the Federal Budget 2021-2022: Impact on the MS Community
12 May 2021
This year’s budget returns us to the annual May budget cycle with a focus on the long-term, following
This year’s budget returns us to the annual May budget cycle with a focus on the long-term, following
“Nobody wants to get a phone call from their doctor on Good Friday. It’s never good news.” It
Disease-modifying therapies (DMTs) are used in MS to target the immune system, but do these DMTs also diminish a person’s capacity to fight infection?
New Australian research has shed light on unique changes in B cells in women with MS, creating avenues for understanding why MS affects more women than men.
With COVID-19 travel restrictions easing, my wife and I took the opportunity to take an extended Easter break
Heat fatigue is a common symptom of MS. Researchers are exploring changes in ability to sweat in people with MS and if this influences heat fatigue.
Italian researchers followed people who had AHSCT up to ten years after the treatment to understand the long-term effectiveness of AHSCT for MS.
The Department of Health has released further details about the Phase 1b roll-out of the COVID-19 vaccination program, including a list of healthcare centres, clinics and GP practices that may begin administering the COVID-19 vaccine from next Monday 22nd March 2021.
There is a large body of circumstantial evidence to suggest that a lack of vitamin D plays a large part in the development of multiple sclerosis (MS).